20
Participants
Start Date
November 30, 2001
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
Valganciclovir
Mayo Clinic, Rochester
Lead Sponsor
Roche Pharma AG
INDUSTRY
Fred Hutchinson Cancer Center
OTHER
City of Hope National Medical Center
OTHER
University of Florida
OTHER
University of Michigan
OTHER
Mayo Clinic
OTHER